Pfizer submits initial data for COVID-19 vaccine in children to FDA | The Hill: Healthcare Policy

Pfizer announced Tuesday that it has submitted initial data to the Food and Drug Administration (FDA) from the trial of its COVID-19 vaccine in children 5-11.  The move is the latest step forward in the closely-watched process of...